Categories: Invest

PulteGroup stock prediction after mixed third-quarter results

On Tuesday, PulteGroup Inc. (NYSE:PHM) shares fell by nearly 4% after announcing its most recent quarterly results. The company reported its fiscal third-quarter revenue and earnings before markets opened, beating the consensus for Street expectations. However, the backlog value increased substantially from the same period a year ago amid persistent supply chain issues.

PulteGroup posted FQ3 non-GAAP earnings per share of $1.82, slightly outperforming the consensus analyst estimate of $1.79. In addition, its GAAP EPS of $1.82 was also $0.04 ahead of estimates, while revenue for the quarter grew by 18% to $3.48 billion, surpassing the average analyst estimate by $50 million.


Are you looking for fast-news, hot-tips and market analysis?

Sign-up for the Invezz newsletter, today.

The company’s backlog increased by a whopping 56% to a value of $10.3 billion.

PulteGroup looks undervalued

From an investment perspective, PulteGroup shares trade at compelling 12-month trailing and forward P/E ratios of 7.79 and 5.27, respectively making the stock an attractive option for value investors.

In addition, analysts expect its earnings per share to grow by 41.60% this year, before rising at an average annual rate of 18.10% over the next five years. Therefore, the stock could also gain the attention of growth investors.

Source – TradingView

Technically, PulteGroup shares seem to have recently plummeted to complete a downward breakout from an ascending channel formation. However, the stock is yet to reach the oversold conditions of the 14-day RSI, thus leaving room for more downward movements.

Therefore, with investors seemingly unwilling to bet on its exciting growth prospects and compelling valuation multiples, they could target extended post-earnings declines at about $46.00 or lower at $44.25.

On the other hand, $49.67 and $51.59 are crucial resistance levels.

Is it safe to buy PHM shares?

In summary, although PulteGroup shares appear to have plunged significantly following Tuesday’s earnings report, the stock is yet to reach oversold conditions.

Therefore, although the stock trades at a cheap valuation whilst offering exciting growth prospects, it may be best to wait for shares to retest current support levels.

Where to buy right now

To invest simply and easily, users need a low-fee broker with a track record of reliability. The following brokers are highly rated, recognised worldwide, and safe to use:

  1. Etoro, trusted by over 13m users worldwide. Register here >
  2. Capital.com, simple, easy to use and regulated. Register here >
admin

Share
Published by
admin

Recent Posts

Is there a way for the crypto sector to avoid Bitcoin’s halving-related bear markets?

There is good reason to be afraid. Previous down markets have seen declines in excess…

2 years ago

UPS and FedEx are good dividend stocks, but which should you take?

United Parcel Service, Inc. (NYSE:UPS) and FedEx Corporation (NYSE:FDX) are two robust logistics companies. Both…

2 years ago

Bitfarms sold 3K Bitcoin as part of strategy to improve liquidity and pay debts

Canadian crypto mining firm Bitfarms sold roughly $62 million worth of Bitcoin (BTC) in June,…

2 years ago

This biotech stock is up 100% on Tuesday: here’s the catalyst

Invezz does not provide financial advice. Our aim is to simplify information about investing, enabling…

2 years ago

Japanese film studio announces the production of a series based on crypto

Noma, a Japanese film studio, has announced that it is producing three feature films that…

2 years ago

Bitcoin price taps 5-day highs as Shiba Inu leads altcoin gains

Bitcoin (BTC) saw continued strength on June 21 as Wall Street trading opened with a…

2 years ago